8500 Square Foot Modular Cancer Research Facility Contract Announced by Art's Way Scientific
Art's Way Manufacturing Co. (NASDAQ:ARTW) announced a significant contract through its subsidiary, Art's Way Scientific, to design a modular research facility comprising 9 units totaling 8,500 square feet. This facility will be constructed for a leading cancer research institution, expected to start early 2023. The project aims to enhance housing and procedural capacity while minimizing site disruption. With this contract and additional projects, Art's Way Scientific's order backlog extends into mid-2023, indicating positive business momentum.
- Secured design contract for an 8,500 square foot modular research facility, enhancing revenue prospects.
- Project expected to start early 2023, indicating upcoming revenue recognition.
- Order backlog extended into mid-2023, suggesting ongoing business momentum.
- None.
MONONA, IA / ACCESSWIRE / November 8, 2022 / Art's Way Manufacturing Co., Inc. (NASDAQ:ARTW), announces its wholly owned subsidiary, Art's Way Scientific, Inc., www.buildingsforscience.com, has executed a design contract for a 9 modular building unit, which will make up an 8,500 square foot research facility. The modular units are currently in design and are expected to be constructed in early 2023. The modular research facility is for one of the world's leading cancer treatment and research institutions.
Mark Tschirgi, General Manager of Art's Way Scientific said, "We are honored to have the opportunity to participate in this significant project. We are serving as the modular building designer and builder on a multi-phased building renovation, upgrade, and new modular research space. We believe this high-profile project has the potential to open the doors to a lot of other opportunities."
The Art's Way Scientific design will integrate into their existing complex, increasing housing and procedural capacity. Being able to work within their restricted space requirements, installing equipment they already own, and walking in on day 1 using the same protocol across their research provides a seamless expansion. There is minimal site disruption and waste with a modular design compared to a traditional site-built option. Sections will be constructed off-site, delivered, and set in place on site.
David King, CEO and Chief Executive Officer, said, "We are grateful for the opportunity to participate in this project with this prestigious institution and valued client. As a result of this contract and other smaller contracts recently awarded to Scientific, our order backlog takes us into mid-2023."
About Art's Way Scientific, Inc. Buildings for Science
Art's Way Scientific, Inc. is a wholly owned subsidiary of Art's Way Manufacturing, Inc. It is the recognized leading supplier of modular laboratories for biocontainment, animal husbandry science, public health, and agricultural animal housing. Art's Way Scientific custom designs, manufactures, delivers, and installs modular laboratories and research facilities to meet customers' specific research requirements. For more information, visit our website at www.buildingsforscience.com.
CONTACT:
David King, CEO
712.208.8467 ext. 200
davidk@artsway.com
www.artsway.com
SOURCE: Art's Way Manufacturing, Inc.
View source version on accesswire.com:
https://www.accesswire.com/723886/8500-Square-Foot-Modular-Cancer-Research-Facility-Contract-Announced-by-Arts-Way-Scientific
